Delivery Order SPE2DB24D2105-SPE2DB24FAPYF
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,851.51 firm fixed price contract is for the supply of 4565406347 – NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
- This federal contract award is a delivery order worth $15,409.92 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $7,555.02, is for the delivery of 4565713292 NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has a period of performance through September 9, 2024 and is a firm-fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division for the supply of NURTEC ODT 75 MG TABLET 8S. The firm-fixed-price contract has a ceiling value of $24,489.72 and a performance period through August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies for the provision of a wide range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $14,469.47 and a period of performance ending on September 13, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The ceiling value of the order is $21,639.48, with a firm fixed price pricing type. The ultimate completion date for this order is October 7, 2024. This contract does not have a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,421.12, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,886.97 firm fixed-price contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product. The contract has an ultimate completion date of July 24, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,178.75 firm-fixed-price contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract has a period of performance through February 20, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,356.34 firm fixed-price contract is for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FAPYFDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $61,551.99 firm fixed-price contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product. The contract does not have a set-aside designation and has a completion date of September 4, 2024. AmerisourceBergen, as a major supplier of pharmaceutical and medical products to the federal government, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other agencies, such as a $999,999,999 IDC with the DLA Troop Support Medical and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, to provide a wide range of critical medical commodities to support government healthcare programs and facilities, including those serving military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.6k | 9/3/24 |